← Back

$ Value

Shares

2,143

Price

Filed

Jul 1

Insider

Name

BOTHA ROELOF

Title

CIK

0001222287

Roles

Director

Transaction Details

Transaction Date

2025-06-27

Code

A

Table

Non-Derivative

Ownership

Direct

Equity Swap

No

Shares After

6,246

Footnotes

Represents the issuance of restricted stock units (RSUs) that shall vest in full on June 12, 2026. The RSUs will become fully vested in the event that the Issuer is subject to a change in control. | Each RSU represents a contingent right to receive one share of the Issuer's Common Stock. | Represents the issuance of RSUs to the Reporting Person. 25% of the RSUs vest immediately and the remaining RSUs vest in three equal quarterly installments thereafter.

Filing Info

Accession No.

0001415889-25-018836

Form Type

4

Issuer CIK

0001604821

BOTHA ROELOF's History

Date Ticker Type Value
2026-04-01 XYZ A $0
2026-01-30 LIFE C $0
2026-01-30 LIFE C $0
2026-01-30 LIFE C $0
2026-01-30 LIFE C $0
2026-01-30 LIFE C $0
2026-01-30 LIFE C $0
2026-01-30 LIFE D $0
2026-01-30 LIFE D $0
2026-01-30 LIFE D $0

Other Insiders at NTRA (90d)

Insider Bought Sold Last
BOTHA ROELOF 2026-01-30
ROSENMAN HERM 2026-01-30
Williams Brinkley Ruth 2026-01-30
Rabinowitz Matthew
EXECUTIVE CHAIRMAN
$38.3M 2026-04-06
Sheena Jonathan $2.4M 2026-04-17
Baynes Roy D. 2026-01-30
Brophy Michael Burkes
CHIEF FINANCIAL OFFICER
$2.9M 2026-03-10
Marcus Gail Boxer 2026-01-30
Chapman Steven Leonard
CEO AND PRESIDENT
$24.1M 2026-03-10
Bertagnolli Monica 2026-01-30
Chapman Rowan E $23K 2026-03-13
RABINOWITZ DANIEL
SEC. AND CHIEF LEGAL OFFICER
$4.5M 2026-04-01
Moshkevich Solomon
PRESIDENT, CLINICALDIAGNOSTICS
$3.0M 2026-04-01
Fesko John
PRESIDENT, CHIEF BUS. OFFICER
$1.4M 2026-03-10